Baseline patient characteristics
| Covariates | No. (%) of patients* n = 13 |
|---|---|
| Age, median [IQR] | 75 [62–84] |
| Male sex | 7 (54) |
| Procedure | |
| Subtotal gastrectomy | 13 (100) |
| Lymphadenectomy | |
| D1+ | 3 (23) |
| D2 | 10 (77) |
| Tumour Location | |
| Proximal third | 1 (8) |
| Middle third | 2 (15) |
| Distal third | 10 (77) |
| pT stage | |
| pT1 | 2 (15) |
| pT2 | 7 (54) |
| pT3 | 3 (23) |
| pT4 | 1 (8) |
| pN stage | |
| pN0 | 9 (69) |
| pN1 | 1 (8) |
| pN2 | 1 (8) |
| pN3 | 2 (15) |
| Classification | |
| Intestinal | 9 (69) |
| Diffuse | 3 (23) |
| Mixed | 1 (8) |
| Grade | |
| 1 | 0 (0) |
| 2 | 8 (62) |
| 3 | 5 (38) |
| ICG Distribution | |
| Outside D1 | 13 (100) |
| Outside D1+ | 7 (54) |
| Outside D2 | 0 (0) |
| No. of LNs, median [IQR] | 26 [24–34] |
| > 16 LNs harvested | 13 (100) |
ICG = Indocyanine green fluorescence; IQR = interquartile range; LN = lymph nodes.
↵* Unless indicated otherwise.